FDA Issues Warning Letter to Colgate-Palmolive/Tom's of Maine
November 19, 2024
November 19, 2024
WASHINGTON, Nov. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Colgate-Palmolive/Tom's of Maine Inc.:
* * *
To: Mr. Noel Wallace, Chief Executive Officer, Colgate-Palmolive/Tom's of Maine, Inc., 300 Park Avenue, New York, NY 10022, United States, Noel_Wallace@colpal.com
Dear Mr. Wallace:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing fac . . .
* * *
To: Mr. Noel Wallace, Chief Executive Officer, Colgate-Palmolive/Tom's of Maine, Inc., 300 Park Avenue, New York, NY 10022, United States, Noel_Wallace@colpal.com
Dear Mr. Wallace:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing fac . . .